Immune therapies for autoimmune diabetes targeting pathogenic peptide–MHC complexes
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Molecular Cell Biology"
DOI: 10.1093/jmcb/mjaa037
Abstract: At present, there is no cure for type 1A diabetes (T1D), a T cell-mediated autoimmune disease. Monoclonal antibodies (mAbs) are used to treat a wide number of diseases. For treating T1D, mAbs that target major… read more here.
Keywords: mhc complexes; peptide mhc; therapies autoimmune; disease ... See more keywords